Abstract:Cell death by ferroptosis results from disrupted iron metabolism, leading to redox‐active Fenton reactions that generate lipid peroxidation. In ischemic stroke, where blood flow to the brain is limited, elevated iron absorption exacerbates oxidative stress, potentially inducing ferroptotic neuronal death. Studies demonstrate the involvement of ferroptosis in ischemic stroke, prompting exploration of ferroptosis‐targeting therapies. Ferroptosis is a unique form of cell death that was first described in 2012 and plays a significant role in various diseases, including neurodegenerative conditions. It depends on a dysregulation of cellular iron metabolism, which increases free, redox‐active, iron that can trigger Fenton reactions, generating hydroxyl radicals that damage cells through oxidative stress and lipid peroxidation. Lipid peroxides, resulting mainly from unsaturated fatty acids, damage cells by disrupting membrane integrity and propagating cell death signals. Moreover, lipid peroxide degradation products can further affect cellular components such as DNA, proteins, and amines. In ischemic stroke, where blood flow to the brain is restricted, there is increased iron absorption, oxidative stress, and compromised blood–brain barrier integrity. Imbalances in iron‐transport and ‐storage proteins increase lipid oxidation and contribute to neuronal damage, thus pointing to the possibility of brain cells, especially neurons, dying from ferroptosis. Here, we review the evidence showing a role of ferroptosis in ischemic stroke, both in recent studies directly assessing this type of cell death, as well as in previous studies showing evidence that can now be revisited with our new knowledge on ferroptosis mechanisms. We also review the efforts made to target ferroptosis in ischemic stroke as a possible treatment to mitigate cellular damage and death.

Iron promotes both ferroptosis and necroptosis in the early stage of reperfusion in ischemic stroke

Ferroptosis and Its Multifaceted Roles in Cerebral Stroke

Insight into the Role of Ferroptosis in Non-neoplastic Neurological Diseases

Single-nucleus transcriptome unveils the role of ferroptosis in ischemic stroke

Mechanism of ferroptosis regulating ischemic stroke and pharmacologically inhibiting ferroptosis in treatment of ischemic stroke

Single-cell and Spatial Transcriptomics Reveals Ferroptosis as The Most Enriched Programmed Cell Death Process in Hemorrhage Stroke-induced Oligodendrocyte-mediated White Matter Injury

The role of ferroptosis as a regulator of oxidative stress in the pathogenesis of ischemic stroke

Mechanism of Ferroptosis and Its Relationships With Other Types of Programmed Cell Death: Insights for Potential Interventions After Intracerebral Hemorrhage

Ferroptosis, a Regulated Neuronal Cell Death Type After Intracerebral Hemorrhage

Ferroptosis in organ ischemia–reperfusion injuries: recent advancements and strategies

Ferroptosis: a Potential Therapeutic Target for Stroke

Ferroptosis and myocardial ischemia-reperfusion: mechanistic insights and new therapeutic perspectives

Ferroptosis occurs in phase of reperfusion but not ischemia in rat heart following ischemia or ischemia/reperfusion

Ferroptosis: Underlying mechanism and the crosstalk with other modes of neuronal death after intracerebral hemorrhage

Targeting ferroptosis: a novel insight against myocardial infarction and ischemia-reperfusion injuries

Ferroptosis in Ischemic Stroke: Animal Models and Mechanisms

Emerging Role of Ferroptosis in the Pathogenesis of Ischemic Stroke: A New Therapeutic Target?

Ferroptosis and endoplasmic reticulum stress in ischemic stroke

Ferroptosis and Iron Metabolism after Intracerebral Hemorrhage

Targeting Ferroptosis as a Promising Therapeutic Strategy for Ischemia-Reperfusion Injury

Targeting Ferroptosis: Pathological Mechanism and Treatment of Ischemia-Reperfusion Injury